Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Data, Analytics & AI · STROBE Checklist

The STROBE Checklist: Reporting Standards for Observational Studies

STROBE provides cohort, case-control and cross-sectional studies with a single 22-item core checklist and a shared numbering scheme. Several items, however, divide into design-specific variants, and use of the incorrect variant of a shared item is consequently one of the most common errors in STROBE compliance.

Pubrica AcademyWritten by an epidemiology writer Reviewed bya biostatistics reviewer Published10 October 2026 Last checked10 October 2026 Reading time8 minutes Sources10 peer-reviewed

STROBE, the Strengthening the Reporting of Observational Studies in Epidemiology statement, is a reporting guideline covering the three main observational study designs (cohort, case-control and cross-sectional studies). It is built around a single core checklist of 22 items, some of which must nonetheless be reported differently according to the design used. It exists because observational studies, unlike randomized trials, cannot rely on randomization to balance confounding factors between groups; transparent reporting of how a study measured, controlled for and analyzed potential sources of bias and confounding is therefore especially important for readers judging how much weight its findings deserve.

Learning objectives

  • The three observational designs covered by STROBE, and why its 22-item checklist requires design-specific variants for some items
  • Why STROBE places special reporting weight on confounding and bias, given that observational studies cannot rely on randomization
  • Common compliance errors, particularly the use of incorrect design-specific wording for a shared item number

Common misconceptions

  • “STROBE is a single, identical 22-item checklist regardless of whether a study is a cohort, case-control, or cross-sectional design.” The STROBE statement explicitly notes that, although the core checklist shares 22 item numbers across all three observational designs, several of those items, including items on study design, participants and statistical methods, require different, design-specific wording for cohort, case-control and cross-sectional studies. The official checklist provides separate combined versions so that authors use the variant appropriate to their design.

Rationale for a dedicated reporting standard for observational studies

Observational studies, in which researchers measure exposures and outcomes as they naturally occur rather than assigning participants to a randomized intervention, cannot rely on randomization to balance known and unknown confounding factors between comparison groups as a randomized trial can. The methods a study used to identify, measure and statistically account for potential confounders are therefore central information for a reader judging whether a reported association reflects a real relationship rather than a confounded one. Von Elm and colleagues developed STROBE specifically to standardize this reporting across the three major observational designs, publishing the statement in the BMJ in 2007 after a two-stage workshop process bringing together methodologists, journal editors and practising epidemiologists1.

A shared 22-item checklist with design-specific variants

STROBE's checklist uses 22 shared item numbers across cohort, case-control, and cross-sectional studies, organized under the familiar headings of title and abstract, introduction, methods, results, and discussion, plus a final item on funding1. The shared numbering is deliberate, intended to let readers and reviewers familiar with STROBE navigate any of the three study types using the same mental structure, but several specific items require different wording depending on the design: item 6 on participants, for example, asks a cohort study to describe eligibility criteria and the sources and methods of selection of participants including methods of follow-up, while asking a case-control study instead to describe eligibility criteria and the sources and methods of case ascertainment and control selection, and asking a cross-sectional study to describe eligibility criteria and the sources and methods of selection of participants at a single point in time2. The official STROBE checklist is published as a combined document listing all three design-specific variants side by side under each shared item number, so that authors can select the correct wording for their study’s design rather than applying one design’s version to another.

Emphasis on reporting of confounding and bias

Several STROBE items are specifically dedicated to confounding and bias in a way that has no direct analogue in CONSORT's checklist for randomized trials, reflecting the different risk profile of observational research. Item 7 requires authors to clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers, with diagnostic criteria where applicable; item 9 requires a description of any efforts made to address potential sources of bias; and item 16 requires reporting of both unadjusted and, if applicable, confounder-adjusted estimates, along with a clear statement of which confounders were adjusted for and why they were chosen3. The STROBE explanation and elaboration paper is explicit that reporting both adjusted and unadjusted estimates together allows a reader to see directly how much a given confounder adjustment changed the result, information that is lost if only the final adjusted estimate is reported on its own3.

Common errors in STROBE compliance

The most common compliance error documented in audits of published observational studies is the use of a design-mismatched version of a shared item, for example applying cohort-study wording to a case-control study’s description of participant selection; the resulting report appears STROBE-compliant at first glance but does not answer the question that the item addresses for that design. A second common error is reporting only a final, fully adjusted effect estimate without the unadjusted estimate called for by STROBE item 16, which prevents the reader from judging how much the confounder adjustment itself changed the finding. A third is addressing potential confounders and biases only in the limitations paragraph of the discussion, rather than in the methods section, where STROBE expects the handling of confounding to be described as part of the analytic approach rather than noted retrospectively as a caveat.

Specialised STROBE extensions for particular types of observational research

Beyond the three core designs, the STROBE Initiative has supported extensions adapting the checklist to specific kinds of observational research that raise their own additional reporting considerations. STROBE-ME, published by Gallo and colleagues in 2011, extends the core checklist to molecular epidemiology studies, adding items specific to biomarker measurement, sample handling, and laboratory methods that the core checklist does not address in sufficient detail for this kind of research4. A separate extension, STREGA, adapts the checklist to genetic association studies, adding items on genotyping methods, Hardy-Weinberg equilibrium, and population stratification that are specific to genetic epidemiology and have no equivalent in the core checklist5. Authors working in one of these specialized areas should identify and apply the relevant extension in addition to the core checklist, since the core items alone will not prompt reporting of the discipline-specific methodological detail that a specialist reader would expect.

Adoption of STROBE and evidence of its effect on reporting

STROBE has been endorsed by a large number of biomedical and epidemiological journals since its 2007 publication, and it is among the reporting guidelines the International Committee of Medical Journal Editors recommends authors consult for the relevant study type6. A bibliographic study by da Costa and colleagues examining how STROBE was cited and used in the published literature found that many papers cited the statement without clear evidence that its items had been systematically applied, suggesting that citation of STROBE is not, by itself, a reliable proxy for genuine compliance, and that authors and reviewers should check specific items directly rather than treating a citation of the STROBE statement as sufficient assurance of complete reporting7.

Deficiencies in reporting quality that motivated the development of STROBE

STROBE was developed in direct response to documented evidence that observational study reporting was inconsistent and often incomplete well before 2007. Pocock and colleagues' survey of recent epidemiological reporting practice, examining a sample of published observational studies, found considerable variation in how basic methodological information, including how confounders were selected and how missing data were handled, was reported across otherwise comparable studies, making it difficult for readers to compare findings or assess risk of bias consistently across the literature8. Around the same period, Grimes and Schulz's widely read series of methodological papers on cohort and case-control study design in The Lancet highlighted specific, recurring design and reporting weaknesses in each study type that readers require sufficient information to detect, including inadequate description of how controls were selected in case-control studies and how loss to follow-up was handled in cohort studies9. STROBE's development process, including its workshop series and consensus-building among methodologists and editors, was built specifically to translate this accumulated evidence of inconsistent reporting into a single, checkable standard rather than leaving each journal or research group to address the problem independently10. This history is useful to authors mainly as a reminder of why each checklist item exists: every one of the 22 items traces back to a specific, documented reporting gap that made some published observational studies harder to interpret or appraise than necessary, rather than to an arbitrary formatting preference. Reading the checklist with this history in mind also makes it easier to apply to a study design that STROBE’s authors did not precisely anticipate, since the question underlying each item (what a careful reader would need to know to judge the result) still applies even where the precise wording requires adaptation.

Key points

Key points

The 22-item STROBE checklist shares its numbering across cohort, case-control and cross-sectional studies, but several items require design-specific wording; the most common compliance error is therefore the application of one design’s version of an item to a study of a different design. Because observational studies cannot rely on randomization, STROBE places particular emphasis on reporting confounding and bias and on presenting adjusted and unadjusted estimates together.

Practical application

Practical application

  1. The precise study design should be confirmed before the checklist wording is selected. Authors should establish whether the study is a cohort, case-control or cross-sectional design before completing the STROBE checklist, and use the wording specific to that design under each shared item number rather than a generic or mismatched version.
  2. Unadjusted and adjusted estimates should be reported together. In accordance with STROBE item 16, the unadjusted effect estimate should be presented alongside the confounder-adjusted estimate, with a clear statement of the confounders adjusted for and the rationale for their selection.
  3. The handling of confounding and bias should be described in the methods, not only in the limitations. The methods section should state explicitly how potential confounders were identified, measured and addressed, treating this as a core component of the analytic approach rather than a caveat reserved for the discussion.

Frequently asked questions

The official STROBE checklist is published as a single combined document, but it lists design-specific wording for several shared item numbers side by side for cohort, case-control, and cross-sectional studies, so authors select the correct variant for their own design within that one document rather than using three entirely separate checklists.

Reporting both allows a reader to see directly how much a confounder adjustment changed the result; reporting only the final adjusted estimate removes the reader's ability to judge the adjustment's actual impact on the finding, which is why STROBE item 16 specifically asks for both.

No. STROBE covers cohort, case-control, and cross-sectional studies specifically; case reports and case series have their own separate reporting guideline (CARE), since they raise different reporting considerations than studies with a defined comparison group or sampling frame.

Yes. The STROBE Initiative has supported several extensions adapting the core checklist to specific types of observational research, including STROBE-ME for molecular epidemiology and related extensions, and the appropriate extension should be consulted alongside the core checklist where a study fits one of these specialized categories.

References

  1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. read 10 October 2026. View on BMJ
  2. STROBE Initiative. STROBE Statement — Checklist of items that should be included in reports of observational studies. read 10 October 2026. View official STROBE checklists
  3. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297. read 10 October 2026. View on PLOS Medicine
  4. Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement. PLoS Med. 2011;8(10):e1001117. read 10 October 2026. View on PLOS Medicine
  5. Little J, Higgins JPT, Ioannidis JPA, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6(2):e22. read 10 October 2026. View on PLOS Medicine
  6. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. read 10 October 2026. View ICMJE Recommendations
  7. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open. 2011;1(1):e000048. read 10 October 2026. View on BMJ Open
  8. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004;329(7471):883. read 10 October 2026. View on BMJ
  9. Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet. 2002;359(9303):341-345. read 10 October 2026. View on The Lancet
  10. Grimes DA, Schulz KF. Case-control studies: research in reverse. Lancet. 2002;359(9304):431-434. read 10 October 2026. View on The Lancet

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). The STROBE Checklist: Reporting Standards for Observational Studies. Pubrica. https://pubrica.com/academy/concepts-definitions/strobe-checklists/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

STROBE Design-Variant Checklist

The study design should be confirmed first, and these design-specific items verified before submission.

[ ] Confirmed study design: cohort / case-control / cross-sectional
[ ] Item 6 (participants) uses the correct design-specific wording for selection/ascertainment
[ ] Item 7: all outcomes, exposures, predictors, confounders, and effect modifiers clearly defined
[ ] Item 9: efforts to address potential sources of bias described in methods
[ ] Item 16: both unadjusted and confounder-adjusted estimates reported, with confounders named and justified
[ ] Confounding/bias handling described in methods section, not only flagged in limitations
[ ] Correct STROBE extension consulted if study fits a specialized category (e.g. molecular epidemiology)

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s epidemiology and manuscript review team assesses observational study reports against the appropriate design-specific STROBE variant, with particular attention to the confounding and bias items that are frequently under-reported.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Pubrica can verify that a study uses the STROBE wording appropriate to its design.

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.